Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Nucleic Acids Res ; 40(19): e150, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22753106

RESUMEN

Transgenesis is a cornerstone of molecular biology. The ability to integrate a specifically engineered piece of DNA into the genome of a living system is fundamental to our efforts to understand life and exploit its implications for medicine, nanotechnology and bioprospecting. However, transgenesis has been hampered by position effects and multi-copy integration problems, which are mainly due to the use of small, plasmid-based transgenes. Large transgenes based on native genomic regions cloned into bacterial artificial chromosomes (BACs) circumvent these problems but are prone to fragmentation. Herein, we report that contrary to widely held notions, large BAC-sized constructs do not prohibit transposition. We also report the first reliable method for BAC transgenesis in human embryonic stem cells (hESCs). The PiggyBac or Sleeping Beauty transposon inverted repeats were integrated into BAC vectors by recombineering, followed by co-lipofection with the corresponding transposase in hESCs to generate robust fluorescent protein reporter lines for OCT4, NANOG, GATA4 and PAX6. BAC transposition delivers several advantages, including increased frequencies of single-copy, full-length integration, which will be useful in all transgenic systems but especially in difficult venues like hESCs.


Asunto(s)
Cromosomas Artificiales Bacterianos , Elementos Transponibles de ADN , Técnicas de Transferencia de Gen , Transgenes , Animales , Línea Celular , Células Madre Embrionarias , Dosificación de Gen , Genes Reporteros , Proteínas de Homeodominio/genética , Humanos , Proteínas Luminiscentes/genética , Ratones , Proteína Homeótica Nanog , Factor 3 de Transcripción de Unión a Octámeros/genética
2.
Genesis ; 48(8): 512-20, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20506501

RESUMEN

Recently, a codon improved version of the Flpe site specific recombinase, termed Flpo, was reported as having greatly improved performance in mammalian cell applications. However, the degree of improvement could not be estimated because essentially no Flpe activity was observed. Here, we compare Flpe and Flpo accurately in a mammalian cell assay to estimate that Flpo is about five times more active than Flpe and similar to Cre and Dre. Consequently, we generated a Flpo deleter mouse line from the JM8 C57Bl/6 ES cells used in the EUCOMM and KOMP systematic knock-out programs. In breeding experiments, we show that the Flpo deleter delivers complete recombination using alleles that are incompletely recombined by a commonly used Flpe deleter. This indicates that the Flpo deleter is more efficient.


Asunto(s)
ADN Nucleotidiltransferasas/metabolismo , Células Madre Embrionarias/metabolismo , Fibroblastos/metabolismo , Animales , Secuencia de Bases , Sitios de Unión/genética , Línea Celular , Células Cultivadas , ADN Nucleotidiltransferasas/genética , Embrión de Mamíferos/citología , Embrión de Mamíferos/metabolismo , Células Madre Embrionarias/citología , Femenino , Fibroblastos/citología , Regulación del Desarrollo de la Expresión Génica , Técnicas de Inactivación de Genes , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Isoenzimas/genética , Isoenzimas/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Plásmidos/genética , Recombinación Genética , Transfección
3.
Genesis ; 48(4): 220-32, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20146354

RESUMEN

Cellular immortalization provides a way for expansion and subsequent molecular characterization of rare cell types. Ideally, immortalization can be achieved by the reversible expression of immortalizing proteins. Here, we describe the use of conditional immortalization based on a modified tetracycline-regulated system for the expression of SV40 large T-antigen in embryonic stem (ES) cells and mice. The modified system relies on a codon improved reverse tetracycline transactivator (irtTA) fused to the ligand-binding domain (LBD) of the androgen receptor (irtTA-ABD) or of a mutated glucocorticoid receptor (irtTA-GBD*). Induction of T-antigen is conferred only after addition of two ligands, one to activate the LBD (mibolerone for irtTA-ABD or dexamethasone for irtTA-GBD*) and one to activate the tetracycline transactivator (doxycycline). In ES cells, changes in gene expression upon large T induction were limited and reversible upon deinduction. Similarly, expression of T-antigen was very tightly regulated in mice. We have isolated and expanded bone marrow mesenchymal stem cells that could be genetically manipulated and maintained their differentiation properties after several passages of expansion under conditions that induce the expression of large T-antigen.


Asunto(s)
Antibacterianos/farmacología , Antígenos Transformadores de Poliomavirus/biosíntesis , Doxiciclina/farmacología , Células Madre Embrionarias/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Receptores Androgénicos/metabolismo , Receptores de Glucocorticoides/metabolismo , Virus 40 de los Simios , Animales , Antiinflamatorios/farmacología , Antígenos Transformadores de Poliomavirus/genética , Línea Celular , Dexametasona/farmacología , Células Madre Embrionarias/citología , Regulación de la Expresión Génica/genética , Ratones , Mutación , Estructura Terciaria de Proteína , Receptores Androgénicos/genética , Receptores de Glucocorticoides/genética
4.
Dis Model Mech ; 2(9-10): 508-15, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19692579

RESUMEN

Tyrosine site-specific recombinases (SSRs) including Cre and FLP are essential tools for DNA and genome engineering. Cre has long been recognized as the best SSR for genome engineering, particularly in mice. Obtaining another SSR that is as good as Cre will be a valuable addition to the genomic toolbox. To this end, we have developed and validated reagents for the Dre-rox system. These include an Escherichia coli-inducible expression vector based on the temperature-sensitive pSC101 plasmid, a mammalian expression vector based on the CAGGs promoter, a rox-lacZ reporter embryonic stem (ES) cell line based on targeting at the Rosa26 locus, the accompanying Rosa26-rox reporter mouse line, and a CAGGs-Dre deleter mouse line. We also show that a Dre-progesterone receptor shows good ligand-responsive induction properties. Furthermore, we show that there is no crossover recombination between Cre-rox or Dre-loxP. Hence, we add another set of efficient tools to the genomic toolbox, which will enable the development of more sophisticated mouse models for the analysis of gene function and disease.


Asunto(s)
ADN Nucleotidiltransferasas/metabolismo , Proteínas de Escherichia coli/metabolismo , Escherichia coli/enzimología , Integrasas/metabolismo , Recombinasas/metabolismo , Animales , Secuencia de Bases , Línea Celular , Células Madre Embrionarias/efectos de los fármacos , Células Madre Embrionarias/metabolismo , Marcación de Gen , Genes Reporteros , Ligandos , Ratones , Mifepristona/farmacología , Datos de Secuencia Molecular , Plásmidos/genética , Progesterona/metabolismo , Células Procariotas/efectos de los fármacos , Células Procariotas/metabolismo , Proteínas/metabolismo , ARN no Traducido , Proteínas Recombinantes de Fusión/metabolismo , Recombinación Genética/efectos de los fármacos , Recombinación Genética/genética , Reproducibilidad de los Resultados
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA